Business

Evogene Schedules Second Quarter 2024 Financial Results Release

Zoom conference call scheduled for 9:00 AM ET REHOVOT, Israel, Aug. 12, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational

Evogene Ltd.August 12, 20243
Evogene Schedules Second Quarter 2024 Financial Results Release

About this update from Evogene Ltd.

Zoom conference call scheduled for 9:00 AM ET REHOVOT, Israel , Aug. 12, 2024 /PRNewswire/ -- Evogene Ltd . (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the second quarter of 2024, on Thursday, August 22, 2024 . Later that day, Company management, will host a conference call to discuss the results at 9:00 AM Eastern Time ( 4:00 PM Israel time). To join the conference, please register in advance: https://us06web.zoom.us/webinar/register/WN_K5GBuG1FQ7Srbe_UJ7r2iQ The entire conference will be available online on the company's website a few days after. About Evogene : Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) is a computational biology company leveraging big data and artificial intelligence, aiming to revolutionize the development of life-science-based products by utilizing cutting-edge technologies to increase the probability of success while reducing development time and cost. Evogene established three unique tech-engines - MicroBoost AI, ChemPass AI and GeneRator AI. Each tech-engine is focused on the discovery and development of products based on one of the following core components: microbes (MicroBoost AI), small molecules (ChemPass AI), and genetic elements (GeneRator AI). Evogene uses its tech-engines to develop products through strategic partnerships and collaborations, and its four subsidiaries including: Biomica Ltd. ( www.biomicamed.com ) - developing and advancing novel microbiome-based therapeutics to treat human disorders powered by MicroBoost AI; Lavie Bio Ltd. ( www.lavie-bio.com ) - developing and commercially advancing, microbiome-based ag-biologicals powered by MicroBoost AI ; AgPlenus Ltd. ( www.agplenus.com ) - developing next-generation ag chemicals for effective and sustainable crop protection powered by ChemPass AI ; Casterra Ag Ltd. ( www.casterra.co ) - developing and marketing superior castor seed varieties producing high yield and high-grade oil content on an industrial scale for the biofuel and other industries powered by GeneRator AI . For more information, please visit: www.evogene.com . Contacts [email protected] Tel: +972-8-9311901 Logo - https://mma.prnewswire.com/media/1947468/Evogene_Logo.jpg View original content: https://www.prnewswire.com/news-releases/evogene-schedules-second-quarter-2024-financial-results-release-302219765.html SOURCE Evogene

View stock analysis, news, and events for Evogene Ltd.

More from Evogene Ltd.

All Evogene Ltd. news →